BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25752357)

  • 1. Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
    Metanat HA; Valizadeh SM; Fakheri H; Maleki I; Taghvaei T; Hosseini V; Bari Z
    Helicobacter; 2015 Aug; 20(4):299-304. PubMed ID: 25752357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.
    Sardarian H; Fakheri H; Hosseini V; Taghvaei T; Maleki I; Mokhtare M
    Helicobacter; 2013 Apr; 18(2):129-34. PubMed ID: 23121338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
    Fakheri H; Taghvaei T; Hosseini V; Bari Z
    Helicobacter; 2012 Feb; 17(1):43-8. PubMed ID: 22221615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
    Mansour NM; Hashash JG; El-Halabi M; Ghaith O; Maasri K; Sukkarieh I; Malli A; Sharara AI
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):865-70. PubMed ID: 21811161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
    Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
    Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
    Bhatia V; Ahuja V; Das B; Bal C; Sharma MP
    J Gastroenterol Hepatol; 2004 Jun; 19(6):619-25. PubMed ID: 15151614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
    Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
    Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
    Oh JH; Dong MS; Choi MG; Yoo HW; Lee SB; Park YI; Chung IS
    J Gastroenterol Hepatol; 2009 Feb; 24(2):294-8. PubMed ID: 18823430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
    Zullo A; Scaccianoce G; De Francesco V; Ruggiero V; D'Ambrosio P; Castorani L; Bonfrate L; Vannella L; Hassan C; Portincasa P
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):647-50. PubMed ID: 23747131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection.
    Sharara AI; Chaar HF; Racoubian E; Moukhachen O; Barada KA; Mourad FH; Araj GF
    Helicobacter; 2004 Jun; 9(3):255-61. PubMed ID: 15165262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
    Boixeda D; Martín De Argila C; Bermejo F; López Sanromán A; Hernández Ranz F; García Plaza A
    Rev Esp Enferm Dig; 2003 Mar; 95(3):206-9, 202-5. PubMed ID: 12760710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
    Zullo A; De Francesco V; Scaccianoce G; Manes G; Efrati C; Hassan C; Maconi G; Piglionica D; Cannaviello C; Panella C; Morini S; Ierardi E
    Dig Liver Dis; 2007 Sep; 39(9):806-10. PubMed ID: 17644057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
    Sierra F; Forero JD; Rey M; Botero ML; Cárdenas A
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1165-71. PubMed ID: 23656465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
    Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.